© 2020 MJH Life Sciences and HCPLive. All rights reserved.
July 30, 2020
There has been controversy over the efficacy and safety of step-therapy for neovascular age-related macular degeneration.
July 29, 2020
No serious adverse events reported through 24 weeks of a 52 week trial.
A perspective on what's moved virtually, and what hasn't, since the pandemic began in March.
Combining the dexamethasone implant with anti-VEGF treatment can restore foveal anatomy in eyes resistant to anti-VEGF injection.
An interview with a Cleveland Clinic investigator on adjusting macular edema screening methods.
July 28, 2020
In a phase 1b study presented virtually during ASRS 2020, investigators found a reduction in central subfield thickness after 12 weeks of OPT-302 combined with aflibercept injections.
The mean number of injections in the studies over 12 months was 9.36 ± 2.66, with a mean change in ETDRS letters was 7.86 ± 1.37.
Interim findings from a cross-sectional study shows a correlation between worse cognitive scoring and a greater rate of intravitreal injections.